Reply to Wang and Lai, and to Woerther et al

Clin Infect Dis. 2020 Dec 3;71(9):2540-2541. doi: 10.1093/cid/ciaa118.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Piperacillin, Tazobactam Drug Combination
  • Pyelonephritis*
  • beta-Lactamases

Substances

  • Piperacillin, Tazobactam Drug Combination
  • beta-Lactamases